Skip to content

National Multicenter Study of Bronchodilator Test in Children and Establishment of Its Standard

National Multicenter Study of Bronchodilator Test in Children and Establishment of Its Standard

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127219
Enrollment
Unknown
Registered
2026-06-26
Start date
2026-06-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

Case group:None
Control group:None

Sponsors

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 17 Years

Inclusion criteria

Inclusion criteria: Case group: 1. Asthmatic children aged 5 - 17 years with normal height and weight; 2. Born in China, with both parents being Chinese; 3. During the acute attack of asthma; 4. No use of nebulization or short-acting bronchodilators within 6 hours before the test, no use of medium-acting bronchodilators within 12 hours, and no use of antihistamines, long-acting bronchodilators, or leukotriene receptor antagonists within 24 hours; 5. Normal intellectual development, able to cooperate well; Control group: 1. Asthmatic children aged 5 - 17 years with normal height and weight; 2. Born in China, with both parents being Chinese; 3. Without allergic diseases such as asthma or rhinitis; 4. No history of respiratory infections or other diseases affecting the respiratory system within one month.

Exclusion criteria

Exclusion criteria: 1. Wheezing not caused by asthma; 2. Having congenital heart, lung or nervous system diseases; 3. Airway malformations; 4. Moderately to severely obese or malnourished individuals; 5. Children who are too short or too tall; 6. Those with severe attacks requiring transfer to the ICU; 7. Those who have already used bronchodilators.

Design outcomes

Primary

MeasureTime frame
Total respiratory impedance;Impedance or resistance;Reactance;Resonance frequency;Reactance area;The volume of exhaled air in the first second;Maximum lung capacity;Maximum expiratory peak flow;The instantaneous exhalation flow during the forced exhalation of 50% of the lung capacity;The instantaneous expiratory flow during the forced exhalation of 75% of the total lung capacity;

Secondary

MeasureTime frame
Age;Gender;Disease status (acute asthma exacerbation,, healthy children);

Countries

China

Contacts

Public ContactZhang Hao

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

zhang123hao2004@163.com+86 21 3862 6161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026